You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Multi-Target Drugs: The Trend of Drug Research and Development
|
|---|---|
| Published in |
PLOS ONE, June 2012
|
| DOI | 10.1371/journal.pone.0040262 |
| Pubmed ID | |
| Authors |
Jin-Jian Lu, Wei Pan, Yuan-Jia Hu, Yi-Tao Wang |
| Abstract |
Summarizing the status of drugs in the market and examining the trend of drug research and development is important in drug discovery. In this study, we compared the drug targets and the market sales of the new molecular entities approved by the U.S. Food and Drug Administration from January 2000 to December 2009. Two networks, namely, the target-target and drug-drug networks, have been set up using the network analysis tools. The multi-target drugs have much more potential, as shown by the network visualization and the market trends. We discussed the possible reasons and proposed the rational strategies for drug research and development in the future. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 290 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 3 | 1% |
| United States | 3 | 1% |
| Spain | 3 | 1% |
| Indonesia | 1 | <1% |
| Pakistan | 1 | <1% |
| Hungary | 1 | <1% |
| Italy | 1 | <1% |
| Austria | 1 | <1% |
| Brazil | 1 | <1% |
| Other | 5 | 2% |
| Unknown | 270 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 74 | 26% |
| Student > Master | 39 | 13% |
| Student > Bachelor | 38 | 13% |
| Researcher | 31 | 11% |
| Student > Postgraduate | 18 | 6% |
| Other | 48 | 17% |
| Unknown | 42 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 67 | 23% |
| Chemistry | 57 | 20% |
| Biochemistry, Genetics and Molecular Biology | 30 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 28 | 10% |
| Medicine and Dentistry | 23 | 8% |
| Other | 26 | 9% |
| Unknown | 59 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2014.
All research outputs
#3,554,737
of 22,669,724 outputs
Outputs from PLOS ONE
#44,010
of 193,515 outputs
Outputs of similar age
#24,494
of 164,182 outputs
Outputs of similar age from PLOS ONE
#760
of 3,987 outputs
Altmetric has tracked 22,669,724 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 193,515 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 3,987 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.